% | $
Quotes you view appear here for quick access.

Cytosorbents Corporation Message Board

  • z3peru z3peru May 14, 2014 11:35 PM Flag

    Fun With Numbers

    Grant income was just under $.5 million, or about 3 times the grant income of 1Q13. CTSO also received about $460K in tax credits. At $.22 per share, the combined total of grants and tax credits avoided 4.6 million shares in dilution.

    At $570K of product income, if Q2 grows at the same rate, i.e 80%, Q2 product income will be over $1 million. Q-over-Q growth can’t be 80% forever, but with new distributors coming online, this high rate is certainly possible.

    R&D expenses in Q1 were $237K as compared to $704K in 1Q13.

    1Q14 loss was $975K. This compares to $1,629 loss in 1Q13. At this pace, CTSO could be at breakeven in 2 more quarters.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
4.45+0.03(+0.68%)May 4 4:00 PMEDT